A phase II clinical trial of the Vascular Disrupting Agent...

Lung Cancer 2013 / 9 Vol. 81; Iss. 3

A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma

Nowak, Anna K., Brown, Chris, Millward, Michael J., Creaney, Jenette, Byrne, Michael J., Hughes, Brett, Kremmidiotis, Gabriel, Bibby, David C., Leske, Annabell F., Mitchell, Paul L.R., Pavlakis, Nick,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
81
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2013.05.006
Date:
September, 2013
File:
PDF, 632 KB
english, 2013
Conversion to is in progress
Conversion to is failed